Humana (NYSE: HUM) reported Q4 EPS of $1.09, $0.07 worse than the analyst estimate of $1.16. Revenue was $12.23 billion, versus the consensus of $12.41 billion.

The company reaffirmed its estimate for EPS for the year ending December 31, 2015 (FY15) to be in the range of $8.50 to $9.00. The company’s 2015 EPS estimate reflects expected strong growth and operating efficiencies in the company’s Medicare offerings, year-over-year improvement in the Healthcare Services businesses, break-even results in its HumanaOne business and reduced investment spending in state-based(b) contracts, partially offset by the tax implications of the expected increase in the non-deductible health insurance industry fee and a reduction in 2015 Medicare rates.

“This past year was particularly dynamic considering Medicare rate reductions, increased income taxes, the launch of healthcare exchanges and our entry into state-based contracts,” said Bruce D. Broussard, President and Chief Executive Officer of Humana. “Our 2014 results in the face of these challenges, combined with strong 2015 membership growth, demonstrate the strength of our consumer-focused strategy and integrated care delivery model. We are pleased with our projected growth trajectory and believe we are well positioned for success in 2015 and beyond.”

For earnings history and earnings-related data on Humana (HUM) click here.